Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 17Colorectal Neoplasms 14Neoplasms 13Carcinoma, Hepatocellular 11Prostatic Neoplasms 7Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Stomach Neoplasms 5Anastomotic Leak 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Disease 4Stomatitis 3Recurrence 3Pancreatic Neoplasms 3Myeloproliferative Disorders 3Lymphoma 3HIV Infections 3Depression 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Vulvar Neoplasms 2Surgical Wound Infection 2Sleep Initiation and Maintenance Disorders 2Skin Neoplasms 2Sarcoma 2Postoperative Complications 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Cytokine Release Syndrome × 90 days × Clear all
NCT07502118 2026-03-30

NexCAR19

Health Institutes of Turkey

Phase 2/3 Recruiting
40 enrolled
Lymphoid

Cytokine Release Syndrome, Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡